Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience

BACKGROUND AND OBJECTIVE: Interstitial lung disease (ILD) remains the number one cause of mortality in scleroderma (SSc). Our goal was to determine the effectiveness of mycophenolate mofetil (MMF) in treating SSc-ILD in a retrospective study. METHODS: A retrospective, computer-assisted search was pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Baqir, Misbah, Makol, Ashima, Osborn, Thomas G., Bartholmai, Brian J., Ryu, Jay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444590/
https://www.ncbi.nlm.nih.gov/pubmed/28542177
http://dx.doi.org/10.1371/journal.pone.0177107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444590/
https://www.ncbi.nlm.nih.gov/pubmed/28542177
http://dx.doi.org/10.1371/journal.pone.0177107

Ejemplares similares